Pfizer CEO Agrees to Lower Drug Prices for Medicaid

Source: Pfizer CEO Albert Bourla agrees to lower prescription drug prices for Medicaid in deal with president, participate in TrumpRx (2025-09-30)

Albert Bourla, the CEO of Pfizer, has agreed to reduce prescription drug prices for Medicaid as part of a deal with the president. This move aims to make medications more affordable for Medicaid recipients and improve access to essential drugs. In addition to the price reduction, Pfizer will participate in TrumpRx, a program focused on lowering drug costs. The agreement marks a significant step toward addressing high medication prices and increasing transparency in the pharmaceutical industry.

More recent coverage

• Cristiano Ronaldo's Goal Tally at Al Nassr Revealed
• Turkey Soccer Champions League Highlights
• Secretary of War Pete Hegseth Addresses Military Leaders
• China's Yuan Stablecoin Launch Signals Blockchain Ambitions
• Fast-Paced Twenty20 Cricket: A Brief Overview
• Martha Plimpton and Tyriq Withers Shine on The Drew Barrymore Show
• Tim Curry Celebrates 50 Years of 'The Rocky Horror Picture Show'
• Serayah Confirms No Friendship with Jacob Latimore